论文部分内容阅读
目的探讨FT3、FT4在结核病疗效评估中的意义。方法选肺结核患者100例(分为痰菌阳性40例,阴性60例),分析抗结核前后的FT3、FT4、ESR变化。结果⑴治疗前菌阳组与菌阴组FT3、FT4、ESR比较,差异均无统计学意义(p>0.05);⑵治疗前后菌阳组FT3、FT4、ESR平均值差异均有统计学意义(p<0.05);⑶菌阴组治疗前后FT3、FT4、ESR平均值差异均无统计学意义(p>0.05)。结论活动性肺结核患者,尤其是痰菌阳性的肺结核患者利用FT3、FT4的变化可作为评估其抗痨疗效的指标之一。
Objective To investigate the significance of FT3 and FT4 in evaluating the curative effect of tuberculosis. Methods 100 cases of tuberculosis patients were divided into sputum positive 40 cases, negative 60 cases before and after anti-tuberculosis FT3, FT4, ESR changes. Results (1) There was no significant difference in FT3, FT4 and ESR between Bacillus subtilis group and Bacteriocin group before treatment (p> 0.05). (2) The average values of FT3, FT4 and ESR in Bacillus positive group before and after treatment were all statistically significant p <0.05). There was no significant difference in average of FT3, FT4 and ESR before and after treatment in patients with bacterial vaginosis (p> 0.05). Conclusion The changes of FT3 and FT4 in patients with active pulmonary tuberculosis, especially sputum positive pulmonary tuberculosis, may be used as one of the indicators to evaluate the anti-tuberculosis efficacy.